Skip to main content
FinSpry Logo
FinSpry
INCY logo
INCY
(NASDAQ)
Incyte Corporation
$116.69-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Incyte (INCY) Stock Price & Financial Analysis

Incyte Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$114.51 - $117.47
52-Week High$119.60
52-Week Low$69.70
Open$115.04
Volume949.20K
Average Volume (3M)1.87M
Market Cap24.13B
Shares Outstanding206.83M
P/E Ratio (TTM)16.86
Forward P/E8.27
Price to Sales (P/S)4.50
Price to Book (P/B)4.29
EV/EBITDA11.07
Revenue (TTM)5.36B
Net Income (TTM)1.43B
Free Cash Flow (TTM)1.42B
EPS (TTM)$7.06
Profit Margin26.71%
Operating Margin27.05%
Return on Equity (ROE)25.46%
Debt to Equity0.01
50-Day MA$106.05
200-Day MA$100.14
52-Week Change65.07%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Incyte

What is the current stock price for INCY?

As of the latest trading session, INCY stock trades at $116.69. The 52-week range is $69.70–$119.60, with a day range of $114.50–$117.47.

What is the P/E ratio for INCY?

Incyte's trailing P/E ratio is 16.9, meaning investors pay $16.9 for every $1 of annual earnings. The forward P/E is 8.3, reflecting analyst expectations for future earnings. Incyte operates in the Healthcare sector.

Does INCY pay dividends?

Incyte does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for INCY?

Based on 24 analysts, the consensus for INCY is Buy.

What is the market cap of INCY?

Incyte's market capitalization is $24.13B, classifying it as a large-cap company. Incyte operates in the Healthcare sector within the Biotechnology industry.